{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:49:35Z","timestamp":1790336975492,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.amjcard.2011.07.025","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T23:46:02Z","timestamp":1315352762000},"page":"1645-1650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Usefulness of Serial N-Terminal Pro\u2013B-Type Natriuretic Peptide Measurements for Determining Prognosis in Patients With Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"108","author":[{"given":"Gert-Jan","family":"Mauritz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Rizopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Groepenhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Tiede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Felix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Eilers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Bosboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter E.","family":"Postmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Westerhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Vonk-Noordegraaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2011.07.025_bib1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1378\/chest.06-1758","article-title":"N-terminal pro\u2013brain natriuretic peptide and renal insufficiency as predictors of mortality in pulmonary hypertension","volume":"131","author":"Leuchte","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2011.07.025_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.amjcard.2006.02.061","article-title":"N-terminal pro\u2013B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension","volume":"98","author":"Andreassen","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2011.07.025_bib3","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1378\/chest.129.5.1313","article-title":"Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension","volume":"129","author":"Fijalkowska","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2011.07.025_bib4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1183\/09031936.00095606","article-title":"NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension","volume":"29","author":"Blyth","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2011.07.025_bib5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1183\/09031936.00016006","article-title":"NT-proBNP reflects right ventricular structure and function in pulmonary hypertension","volume":"28","author":"Gan","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2011.07.025_bib6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jacc.2009.08.060","article-title":"Improving risk stratification for heart failure","volume":"55","author":"Daly","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"suppl","key":"10.1016\/j.amjcard.2011.07.025_bib7","first-page":"e23","article-title":"Incremental prognostic value of changes in B-type natriuretic peptide in heart failure","volume":"119","author":"Latini","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2011.07.025_bib8","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro\u2013brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)","volume":"52","author":"Masson","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2011.07.025_bib9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ahj.2006.08.021","article-title":"Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results","volume":"152","author":"Wu","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2011.07.025_bib10","series-title":"Linear Mixed Models for Longitudinal Data","author":"Verbeke","year":"2000"},{"key":"10.1016\/j.amjcard.2011.07.025_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1183\/09031936.05.00100504","article-title":"N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension","volume":"25","author":"Souza","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2011.07.025_bib12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2011.07.025_bib13","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1002\/art.11345","article-title":"N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers","volume":"48","author":"Allanore","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.amjcard.2011.07.025_bib14","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0954-6111(03)00254-3","article-title":"Significance of plasma N-terminal pro\u2013brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension","volume":"97","author":"Mukerjee","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.amjcard.2011.07.025_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/rheumatology\/keh486","article-title":"Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992\u20132001","volume":"44","author":"Hesselstrand","year":"2005","journal-title":"Rheumatology (Oxf)"},{"key":"10.1016\/j.amjcard.2011.07.025_bib16","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1093\/eurheartj\/ehi410","article-title":"What is the normal range for N-terminal pro\u2013brain natriuretic peptide?","volume":"26","author":"Galasko","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2011.07.025_bib17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.110.156547","article-title":"Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress","volume":"56","author":"Maeder","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2011.07.025_bib18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1183\/09031936.00001407","article-title":"Right ventricular ejection fraction and NT-proBNP are both indicators of wall stress in pulmonary hypertension","volume":"29","author":"Vonk Noordegraaf","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.amjcard.2011.07.025_bib19","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jacc.2008.06.026","article-title":"Serial measurements of plasma B-type natriuretic peptides: what do they tell us?","volume":"52","author":"Richards","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2011.07.025_bib20","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0735-1097(02)02012-0","article-title":"Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival","volume":"40","author":"Sitbon","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2011.07.025_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.07.025_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"issue":"suppl","key":"10.1016\/j.amjcard.2011.07.025_bib23","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1378\/chest.126.1_suppl.78S","article-title":"Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McLaughlin","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.amjcard.2011.07.025_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCULATIONAHA.110.963983","article-title":"Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases","volume":"122","author":"McLaughlin","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2011.07.025_bib25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914911023034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914911023034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:02:20Z","timestamp":1762077740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914911023034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0002914911023034"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2011.07.025","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of Serial N-Terminal Pro\u2013B-Type Natriuretic Peptide Measurements for Determining Prognosis in Patients With Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2011.07.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}